SB 527
Approved by Governor-Chapter 809 (effective 7/1/2026)
Pharmaceutical Substance Manufacturing Grant Fund; created.
- Virginia
- Senate
- Introduced Jan 13, 2026
- Session 2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Virginia’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
29 actions-
Approved by Governor-Chapter 809 (effective 7/1/2026)
-
Governor's Action Deadline 11:59 p.m., April 13, 2026
-
Enrolled Bill communicated to Governor on March 10, 2026
-
Signed by President
-
Signed by Speaker
-
Fiscal Impact Statement from Department of Planning and Budget (SB527)
-
Bill text as passed Senate and House (SB527ER)
-
Enrolled
-
Passed House (92-Y 6-N 0-A)
-
Read third time
-
Moved from Uncontested Calendar to Regular Calendar
-
Read second time
-
Reported from Appropriations (22-Y 0-N)
-
Assigned HAPP sub: Commerce Agriculture & Natural Resources
-
Referred to Committee on Appropriations
-
Read first time
-
Placed on Calendar
-
Read third time and passed Senate (39-Y 0-N 0-A)
-
Engrossed by Senate (Voice Vote)
-
Read second time
-
Passed by for the day Block Vote (Voice Vote)
-
Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
-
Rules suspended
-
Reported from Finance and Appropriations (14-Y 0-N)
-
Rereferred from Commerce and Labor to Finance and Appropriations (11-Y 0-N)
-
Fiscal Impact Statement from Department of Planning and Budget (SB527)
-
Rereferred from Education and Health to Commerce and Labor (14-Y 0-N)
-
Referred to Committee on Education and Health
-
Prefiled and ordered printed; Offered 01-14-2026 26102905D